🔗 Permalink

Inventor profile of:

Markus Hossbach

City:

Kulmbach

Country:

Germany

Published Applications:

Last publication date:

2026-02-26

Top Assignees for applications by Markus Hossbach

The entities that hold a legal rights for patent applications filed by inventor Hossbach Markus:

ALIGOS THERAPEUTICS, INC. 6 South San Francisco, CA United States
Voyager Therapeutics, Inc. 4 Cambridge, MA United States
MINA THERAPEUTICS LIMITED 3 London, United Kingdom
Arrowhead Pharmaceuticals, Inc. 3 Pasadena, CA United States
ARROWHEAD RESEARCH CORPORATION 2 Pasadena, CA United States
VOYAGER THERAPEUTICS, INC. 2 Lexington, MA United States
NEUROVISION PHARMA GMBH 2 Grünwald, Germany
Dyne Therapeutics, Inc. 1 Waltham, MA United States
ARROWHEAD MADISON INC. 1 Madison, WI United States
Genentech, Inc. 1 South San Francisco, CA United States
PhaseRx, Inc. 1 Seattle, WA United States

Recent patent applications by Hossbach Markus

Markus Hossbach from Kulmbach, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-02-26

US20260053941A1

Human necessities

MUSCLE TARGETING COMPLEXES AND FORMULATIONS FOR TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

#2 | 2026-01-01

US20260002157A1

Chemistry; metallurgy

MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) MOLECULES AND USES THEREOF

#3 | 2025-05-08

US20250146000A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS OF TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS)

#4 | 2024-12-19

US20240415868A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING HUNTINGTON'S DISEASE

#5 | 2024-07-11

US20240226203A9

Human necessities

COMPOSITIONS AND METHODS OF TREATING HUNTINGTON'S DISEASE

#6 | 2024-04-25

US20240131093A1

Human necessities

COMPOSITIONS AND METHODS OF TREATING HUNTINGTON'S DISEASE

#7 | 2024-02-01

US20240035026A9

Chemistry; metallurgy

HNF4A SARNA COMPOSITIONS AND METHODS OF USE

#8 | 2023-11-16

US20230365970A1

Chemistry; metallurgy

Modified short interfering nucleic acid (siNA) molecules and uses thereof

#9 | 2023-10-19

US20230332156A1

Chemistry; metallurgy

Compositions and methods of treating amyotrophic lateral sclerosis (ALS)

#10 | 2023-10-19

US20230332153A1

Chemistry; metallurgy

Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses Thereof

#11 | 2023-05-25

US20230159929A1

Chemistry; metallurgy

MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) MOLECULES AND USES THEREOF

#12 | 2023-03-30

US20230095695A1

Chemistry; metallurgy

RNAS FOR COMPLEMENT INHIBITION

#13 | 2022-11-17

US20220364096A1

Chemistry; metallurgy

Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses Thereof

#14 | 2022-06-09

US20220177888A1

Chemistry; metallurgy

Modified short interfering nucleic acid (siNA) molecules and uses thereof

#15 | 2022-05-12

US20220143071A1

Human necessities

ANTISENSE-OLIGONUCLEOTIDES AS INHIBITORS OF TGF-R SIGNALING

#16 | 2022-03-24

US20220090074A1

Chemistry; metallurgy

HNF4a saRNA compositions and methods of use

#17 | 2021-06-24

US20210187007A1

Human necessities

C/EBP ALPHA SARNA COMPOSITIONS AND METHODS OF USE

#18 | 2021-05-13

US20210139915A1

Chemistry; metallurgy

Compositions and methods of treating amyotrophic lateral sclerosis (ALS)

#19 | 2020-12-03

US20200376020A1

Human necessities

C/EBP alpha saRNA compositions and methods of use

#20 | 2020-09-03

US20200277610A1

Chemistry; metallurgy

Compositions and methods for inhibiting expression of RRM2 genes

#21 | 2020-08-13

US20200255826A1

Chemistry; metallurgy

HNF4A saRNA compositions and methods of use

#22 | 2020-05-21

US20200157547A1

Chemistry; metallurgy

Compositions and methods of treating amyotrophic lateral sclerosis (ALS)

#23 | 2020-05-21

US20200155624A1

Human necessities

Compositions and methods of treating Huntington's disease

#24 | 2019-10-17

US20190314401A1

Human necessities

ANTISENSE-OLIGONUCLEOTIDES AS INHIBITORS OF TGF-R SIGNALING

#25 | 2019-05-30

US20190160091A1

Human necessities

Compositions and methods for treating Huntington's disease

#26 | 2018-10-04

US20180282732A1

Chemistry; metallurgy

Compositions and methods of treating amyotrophic lateral sclerosis (ALS)

#27 | 2018-07-12

US20180195074A1

Chemistry; metallurgy

Compositions and methods for inhibiting expression of RRM2 genes

#28 | 2017-11-09

US20170319614A1

Human necessities

Antisense-oligonucleotides as inhibitors of TGF-R signaling

#29 | 2017-05-18

US20170137827A1

Chemistry; metallurgy

Compositions and methods for inhibiting expression of RRM2 genes

#30 | 2016-05-19

US20160138029A1

Chemistry; metallurgy

Antisense-oligonucleotides as inhibitors of TGF-R signaling

#31 | 2015-11-26

US20150337318A1

Chemistry; metallurgy

RNA TARGETED TO C-MET

#32 | 2015-10-15

US20150291956A1

Chemistry; metallurgy

RNA TARGETED TO BETA CATENIN

#33 | 2015-04-23

US20150113670A1

Chemistry; metallurgy

Compositions and Methods for Inhibiting Expression of RRM2 Genes

#34 | 2013-01-03

US20130005793A1

Human necessities

Compositions and methods for inhibiting gene expression of hepatitis B virus

#35 | 2012-06-21

US20120159657A1

Chemistry; metallurgy

Compositions and methods for inhibiting expression of RRM2 genes

#36 | 2011-08-11

US20110196016A1

Chemistry; metallurgy

Compositions and Methods for Inhibiting Expression of IKK2 Genes

#37 | 2011-06-23

US20110152349A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF IL-18 GENES

#38 | 2011-05-19

US20110119781A1

Chemistry; metallurgy

Compositions and Methods for Inhibiting Expression of TGF-BETA Receptor Genes

#39 | 2011-05-12

US20110112176A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF KIF10 GENES

#40 | 2011-01-27

US20110020300A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF GLUCOCORTICOID RECEPTOR (GCR) GENES

#41 | 2010-08-05

US20100197773A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF PTP1B GENES

#42 | 2010-05-20

US20100124547A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF FACTOR VII GENES

InventorID:

14191 ⎘